Loco-regional drug delivery in oncology: current clinical applications and future translational opportunities
Authors:
- 16 December 2020
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 18 (5) , 607-623
Abstract
Introduction: Drug-based treatment regimens for cancer are often associated with off-target toxic side effects and low penetration of the drug at the tumor site leading to patient morbidity and limited efficacy. Loco-regional drug delivery has the potential to increase efficacy while concomitantly reducing toxicity. Areas covered: Clinical applications using loco-regional delivery include intra-arterial drug delivery in retinoblastoma, direct intra-tumoral (IT) injection of ethanol for ablation in hepatocellular carcinoma (HCC) and the use of HIPEC in peritoneal carcinomas. In recent years, there has been a significant increase in both approved products and clinical trials, with a particular emphasis on drug delivery platforms such as drug eluting beads for HCC and hydrogel platforms for intravesical delivery in bladder cancer. Expert opinion: Development of loco-regional drug delivery systems has been slow, limited by weak clinical data for early applications and challenges relating to dosing, delivery and retention of drugs at the site of action. However, there is increasing focus on the potential of loco-regional drug delivery when combined with bespoke drug delivery platforms. With the growth in immunotherapies, the use of IT delivery to drive priming of the anti-tumor response has opened up a new field of opportunity for loco-regional drug delivery.Keywords
Funding Information
- Clement Archer Scholarship, Royal College of Surgeons in Ireland
This publication has 123 references indexed in Scilit:
- Cancer immunotherapies, their safety and toxicityExpert Opinion on Drug Safety, 2013
- Current status of embolic agents for liver tumor embolizationInternational Journal of Clinical Oncology, 2012
- Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastomaActa Neurochirurgica, 2012
- Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafersJournal of Controlled Release, 2012
- Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine TumorsInternational Journal of Hepatology, 2012
- Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomasNeuro-Oncology, 2011
- Hyperthermic intraperitoneal chemotherapy: Rationale and techniqueWorld Journal of Gastrointestinal Oncology, 2010
- Liver Anatomy: Microcirculation of the LiverSeminars in Interventional Radiology, 2008
- The natural compound n‐butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3Journal of Neurochemistry, 2006
- Percutaneous ablation of hepatocellular carcinoma: State-of-the-artLiver Transplantation, 2004